PLAU and rheumatoid arthritis: From this perspective, considering the growing utilization of suPAR as a biomarker for monitoring Systemic Chronic Inflammation (SCI) [41], we investigated the effects due to uPA/uPAR interaction in the immune cells involved in RA onset and progression [42].